Oxford OXLCI Q4 2025 Earnings Miss EPS 255 vs 275 Expected Intel CEO Signals Foundry Traction as Customer Interest Accelerates Champions Onc CSBR Q1 2026 Results Fall Short EPS 002 Revenue NA Paysign PAYS Q1 2026 Earnings Why the Beat Matters Klaviyo KVYO Faces Oversold Territory Amid AI Sector Volatility General Motors Introduces AllElectric Cadillac Vistiq with 300Mile Range Global Infrastructure Funding Surges as Japanese Banks Lead FiveYear Doubling Traders Bet on IonQ Micron Anduril as Next Potential US Government Stake Targets The Just One More Year Dilemma Should a 60YearOld With 15M Quit Their Hated Job The Hidden Cost of Financial Pretense Why Some Couples Hide Their Wealth TSM Q1 2026 Earnings EPS Crushes Estimates as AI Demand Fuels Record Profitability TELO Q4 2025 Earnings WiderthanExpected Loss Stings as PreRevenue Biotech Focuses on Pipeline CBK Q1 2026 Earnings Earnings Beat Despite Stock Decline ISBA Q1 2026 Earnings Deep EPS Miss Stirs Concern Among Investors IP Q1 2026 Earnings Modest EPS Beat Supports Positive Sentiment AAOI Q1 2026 Earnings EPS Misses Estimates as Investors Focus on LongTerm Strategy Cabot Corporation CBT Holds Near Support Modest Price Recovery May Signal Consolidation K2 Capital Acquisition Rights KTWOR Jump 1579 as Speculation Builds Around Potential Merger Completion Adial Pharmaceuticals ADIL Drops 957 as Selling Pressure Mounts Near Key Support WidePoint Corporation WYY Surges 11 as Support Holds Strong Marzetti Company MZTI Holds Near 114 as Slight Loss Reflects Cautious Trading Goldman Sachs CD Offering at 4 Outpaces Average Bank Rates Immunome Inc Q1 2026 Earnings NarrowerThanExpected Loss Amid No Revenue Stock Slips Ekso Bionics EKSO Gains Ground as Shares Approach Key Resistance EU Negotiators Reach Partial Agreement on EUUS Trade Deal Safeguards Implementation Talks Continue Under Tariff Pressure JetAI JTAI Q1 2026 Results Fall Short EPS 668 Revenue NA Mortgage Costs Surge as Middle East Tensions Rattle Global Bond Markets Goldline Pharmaceutical IPO Allotment Status Today Key Dates GMP and How to Check Allocation Neumora Therapeutics NMRA Crushes Q1 2026 Estimates EPS 030 Tops Views Accuray ARAY Slides 520 as Selling Pressure Mounts 20260515 Nauticus KITTW Slips 1888 Testing 003 Support 20260513